Eyebright Medical Technology Beijing Co Ltd Cash Flow Conversion Efficiency
Eyebright Medical Technology Beijing Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million ≈ $11.26 Million USD) by net assets (CN¥3.01 Billion ≈ $440.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Eyebright Medical Technology Beijing Co Ltd (2016–2025)
Cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Eyebright Medical Technology Beijing Co for real-time trading data and today's change.
Eyebright Medical Technology Beijing Co Ltd Cash Flow Conversion Ratio Explained
Eyebright Medical Technology Beijing Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency. Also see 688050 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nhn Entertain
KO:181710
|
-0.025x |
|
Tibet Urban Development and Investment Co Ltd
SHG:600773
|
-0.009x |
|
Canfor Corporation
TO:CFP
|
0.079x |
|
Gansu Guofang Gongmao(Grp)
SHG:601086
|
0.031x |
|
Everi Holdings Inc
NYSE:EVRI
|
1.295x |
|
Shenzhen Beauty Star Co Ltd
SHE:002243
|
0.009x |
|
Nutex Health Inc
NASDAQ:NUTX
|
0.067x |
|
Wolfspeed, Inc.
NYSE:WOLF
|
-0.058x |
Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. Review 688050 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.97 Billion ≈ $434.64 Million |
CN¥369.15 Million ≈ $54.02 Million |
0.124x | -5.86% |
| 2024-12-31 | CN¥2.63 Billion ≈ $385.47 Million |
CN¥347.75 Million ≈ $50.89 Million |
0.132x | +37.45% |
| 2023-12-31 | CN¥2.36 Billion ≈ $344.75 Million |
CN¥226.27 Million ≈ $33.11 Million |
0.096x | -26.27% |
| 2022-12-31 | CN¥1.92 Billion ≈ $280.98 Million |
CN¥250.13 Million ≈ $36.60 Million |
0.130x | +3.37% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
CN¥219.30 Million ≈ $32.09 Million |
0.126x | +58.11% |
| 2020-12-31 | CN¥1.55 Billion ≈ $226.47 Million |
CN¥123.35 Million ≈ $18.05 Million |
0.080x | +2.21% |
| 2019-12-31 | CN¥647.52 Million ≈ $94.75 Million |
CN¥50.49 Million ≈ $7.39 Million |
0.078x | +35.73% |
| 2018-12-31 | CN¥553.87 Million ≈ $81.05 Million |
CN¥31.82 Million ≈ $4.66 Million |
0.057x | +174.70% |
| 2017-12-31 | CN¥198.44 Million ≈ $29.04 Million |
CN¥4.15 Million ≈ $607.32K |
0.021x | +216.46% |
| 2016-12-31 | CN¥187.52 Million ≈ $27.44 Million |
CN¥-3.37 Million ≈ $-492.75K |
-0.018x | -- |
About Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more